Suzhou Zelgen Biopharmaceuticals Co., Ltd. (SHA:688266)

China · Delayed Price · Currency is CNY

110.00

+3.34 (3.13%)

Sep 30, 2026, 3:00 PM CST

SHA:688266 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	29,118	24,538	16,494	14,014	10,008	14,112
Market Cap Growth	1.64%	48.77%	17.70%	40.02%	-29.08%	-9.11%
Enterprise Value	27,461	23,578	15,213	12,658	9,443	13,028
Last Close Price	110.00	92.70	62.31	52.94	41.70	58.80

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	59.46	35.51	35.51	35.51	35.51	-
PS Ratio	17.75	30.28	30.95	36.26	33.11	74.13
PB Ratio	16.92	22.71	13.17	8.52	12.71	11.26
P/TBV Ratio	17.17	23.37	13.70	8.96	14.98	13.07
P/OCF Ratio	36.55	-	431.73	-	-	-

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	16.74	29.09	28.54	32.76	31.24	68.44

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.47	1.05	0.83	0.54	0.70	0.18
Net Debt / Equity Ratio	-0.96	-0.83	-0.92	-0.83	-0.63	-0.78
Net Debt / EBITDA Ratio	-3.34	4.47	6.65	3.82	1.03	2.11
Net Debt / FCF Ratio	-2.57	4.27	20.09	4.60	1.09	1.86
Asset Turnover	0.50	0.27	0.18	0.17	0.18	0.10
Inventory Turnover	0.61	0.46	0.26	0.30	0.37	0.19
Quick Ratio	2.26	1.54	1.71	2.08	1.57	3.35
Current Ratio	2.50	1.71	1.88	2.22	1.77	3.69
Return on Equity (ROE)	38.00%	-14.16%	-10.37%	-24.27%	-47.59%	-31.38%
Return on Assets (ROA)	8.80%	-5.08%	-4.60%	-10.91%	-19.70%	-17.02%
Return on Capital Employed (ROCE)	19.60%	-15.80%	-13.30%	-22.70%	-57.30%	-37.10%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	1.89%	-0.66%	-0.84%	-1.99%	-4.57%	-3.20%
FCF Yield	2.22%	-0.86%	-0.35%	-2.11%	-4.59%	-3.72%
Buyback Yield / Dilution	-1.16%	0.85%	-3.71%	-6.74%	0.19%	-2.20%